A Multi-centre Study to Assess the Long-term Performance of the Silent Hip™ in Primary Total Hip Replacement Surgery

NCT ID: NCT01383824

Last Updated: 2016-05-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

89 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2015-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to monitor the performance and of the Silent Hip™ in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Arthritis Secondary Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Silent™ Hip

A short cementless, femoral component for use in total hip arthroplasty

Group Type OTHER

Silent™ Hip

Intervention Type DEVICE

A short cementless, femoral component for use in total hip arthroplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Silent™ Hip

A short cementless, femoral component for use in total hip arthroplasty

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any subject deemed suitable to receive the Silent™ Hip in combination with the Pinnacle™ acetabular cup system, in accordance with all applicable Instructions For Use, should be considered for entry into this study.

Exclusion Criteria

* Subjects who, in the opinion of the Investigator, have an existing condition/co-morbidity or infection that would compromise their long-term participation and follow-up in this study.
Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

DePuy International

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sygehus Sønderjyllands

Sønderborg, , Denmark

Site Status

Orthopädie Kupfalz

Speyer, , Germany

Site Status

Orthopaedic Clinic University La Sapienza

Rome, , Italy

Site Status

Hospital Nisa Sevilla-Aljarafe

Seville, , Spain

Site Status

Hospital San Juan de Dios del Aljarafe

Seville, , Spain

Site Status

Hospital Santa Ángela De La Cruz

Seville, , Spain

Site Status

Princess Alexandra Hospital

Harlow, Essex, United Kingdom

Site Status

The Rivers Hospital

Sawbridgeworth, Hertfordshire, United Kingdom

Site Status

Wrightington Hospital

Wrightington, Lancashire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark Germany Italy Spain United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CT09/02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CoMplete™ Acetabular Hip System
NCT01543230 TERMINATED NA
Avenir® Cemented Hip Stem - PMCF
NCT03396224 ACTIVE_NOT_RECRUITING
CoreHip - Post Market Clinical Follow-Up Study
NCT03685110 ACTIVE_NOT_RECRUITING